Categories: Top News

EmblemHealth Appoints New Chief Medical Officer

New York, New York, Feb. 11, 2025 (GLOBE NEWSWIRE) — EmblemHealth, one of the nation’s largest not-for-profit health insurers, today announced the appointment of Dr. Daniel Knecht as its new Chief Medical Officer. As CMO, Dr. Knecht will lead the health plan’s clinical strategy which includes innovating care models, improving health outcomes, and enhancing the value of care provided to more than 2 million New Yorkers.

“We are thrilled to welcome Dr. Knecht to EmblemHealth,” said Mike Palmateer, CEO of EmblemHealth. “His deep clinical experience and passion for innovation will be instrumental as we continue to transform care delivery. With Dr. Knecht’s forward-thinking leadership, we are positioned to drive meaningful change, improve health outcomes, and deliver even greater value to the millions of New Yorkers we serve.”

Dr. Knecht brings an extensive wealth of clinical and leadership experience to his new role as CMO. Most recently he served as Chief Clinical Innovation Officer at CVS Caremark where he led the enterprise strategies to enhance patient outcomes, improve healthcare costs, and elevate care delivery. And, previously, as Vice President of Clinical Strategy and Policy at Aetna where he focused on population health, behavioral integration, and addressing social determinants of health. He is a board-certified internist affiliated with Mount Sinai. 

“I am honored to join an organization with such a rich legacy of serving communities and improving lives,” expressed Dr. Knecht. “I look forward to working with the talented team at EmblemHealth to innovate and deliver meaningful health care solutions that put members first. By leveraging our community-based capabilities like AdvantageCare Physicians (ACNPY) and Neighborhood Care locations, we can foster healthier outcomes for New Yorkers.”

Dr. Knecht holds an MD/MBA from Weill Cornell Medical College and a BA in Biochemistry and Molecular Biology from Dartmouth College. A Fullbright Scholar and Modern Healthcare 40 Under 40 honoree, he is an active board member of CUNY School of Public Health Foundation, committed to building a future pipeline of outstanding talent for our health care system.

About EmblemHealth
EmblemHealth is one of the nation’s largest not for profit health insurers, serving members across New York’s diverse communities with a full range of commercial and government-sponsored health plans for employers, individuals, and families. With a commitment to value-based care, EmblemHealth partners with top hospitals and doctors, including its own AdvantageCare Physicians, to deliver quality, affordable, convenient care. At over a dozen EmblemHealth Neighborhood Care locations, members and non-members alike have access to community-based health and wellness guidance and resources. For more information, visit emblemhealth.com.

Contact: 
EmblemHealth Public Relations Office| Email: press@emblemhealth.com

CONTACT: Alex Gomez
EmblemHealth
agomez@emblemhealth.com

Latest posts by GlobeNewswire (see all)
GlobeNewswire

GlobeNewswire, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Recent Posts

Board Change

Board Change Serabi Gold plc (“Serabi” or the “Company”) (AIM: SRB, TSX: SBI, OTCQX :…

41 minutes ago

Recording of LHV Group’s 22 April investor webinar

To give an overview of the 2025 Q1 financial results, LHV Group organised an investor…

58 minutes ago

Telix Reports US$186M Q1 Revenue, Up 62% YOY

MELBOURNE, Australia and INDIANAPOLIS, April 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX,…

2 hours ago

Litmos Adds to AI Product Portfolio

Newest AI enhancement to the Content Authoring Tool (CAT) affirms Litmos’ mission to create better…

2 hours ago

Graphene Market worth $2.94 billion by 2029, at a CAGR of 24.0%, says MarketsandMarkets™

Delray Beach, FL, April 22, 2025 (GLOBE NEWSWIRE) -- The Graphene Market is projected to grow…

2 hours ago

Danske Bank share buy-back programme: transactions in week 16

  Company announcement no. 19 2025Danske BankBernstorffsgade 40DK-1577 København VTel. + 45 33 44 00…

2 hours ago

This website uses cookies.